PATENT CLAIM ANALYSIS

Application Number: 15897032
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-10
Patent Classification: ["514", "001000"]

Abstract:
Methods and compositions are provided for treating hyperproliferative disorders in patients with a PI3K inhibitor, GDC-0032 as a single agent or in combination with chemotherapeutic agents.

Claim (Index 23):
The method of  claim 20  wherein the pharmaceutically acceptable salt of GDC-0032 is selected from a salt formed with hydrochloric acid, hydrobromic acid, hydroiodic acid, sulfuric acid, nitric acid, phosphoric acid, methanesulfonic acid, benzenesulfonic acid, formic acid, acetic acid, trifluoroacetic acid, propionic acid, oxalic acid, malonic acid, succinic acid, fumaric acid, maleic acid, lactic acid, malic acid, tartaric acid, citric acid, ethanesulfonic acid, aspartic acid and glutamic acid.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 88.0
- Lexical Diversity: 1.12
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13912281', '12208227', '12400988', '13109670', '15438277']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8204222252909242
- 35 USC 102 Novelty (BERT): 0.7293794713722105
- Combined Prediction Score: 0.8113179498990528
- Mean Citation Score: 568.5882720000002
- Max Citation Score: 967.9128
- Similarity Product: 786.4986112867356

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test